March 1, 2017 | PharmaNewsDaily.com
Skip to content
PharmaNewsDaily.com
Coverage of Global Pharma Industry News
Home
Pharma Industry News
Pharma Regulatory News
Clinical Trial News
About
Contact
Terms
Privacy
Disclaimer
Month: March 2017
Lilly’s breast cancer drug abemaciclib meets objective in phase 3 trial
Posted on March 22, 2017 November 10, 2018 by pharmanewsdaily
Indianapolis-based Lilly has reported that its breast cancer drug, abemaciclib, in combination with fulvestrant, has yielded positive results by meeting
Continue reading
Clinical Trial News
Leave a comment
New oral blood thinner rivaroxaban from Bayer and Jannsen shown to cut recurrence of life-threatening blood clots
Posted on March 19, 2017 November 10, 2018 by pharmanewsdaily
Bayer and Janssen Pharmaceuticals have revealed that their jointly developed oral blood thinner Xarelto (rivaroxaban) had considerably brought down the
Continue reading
Clinical Trial News
Leave a comment
Astrazeneca ovarian cancer drug Lynparza shown to improve survival chances
Posted on March 18, 2017 November 10, 2018 by pharmanewsdaily
Pharma giant AstraZeneca has reported that its ovarian cancer drug Lynparza (olaparib) as a maintenance therapy has considerably improved the
Continue reading
Clinical Trial News
Leave a comment
Amgen cholesterol injection Repatha reduces heart attack, stroke chances
Posted on March 18, 2017 November 10, 2018 by pharmanewsdaily
Amgen cholesterol injection Repatha (evolocumab) has been demonstrated to have cut heart attack and stroke risk by 20% in a
Continue reading
Clinical Trial News
Leave a comment
Tigenix’ heart attack stem cell therapy trial delivers positive results
Posted on March 13, 2017 November 10, 2018 by pharmanewsdaily
TiGenix has announced that its cardiac stem cell study assessing its heart attack stem cell therapy with AlloCSC-01 was successful in
Continue reading
Clinical Trial News
Leave a comment
Servier, Pfizer given FDA green signal for lymphoblastic leukemia drug
Posted on March 12, 2017 November 10, 2018 by pharmanewsdaily
The US Food and Drug Administration (FDA) has given the green signal to Servier and Pfizer to carry out the
Continue reading
Pharma Regulatory News
Leave a comment
Actelion’s Ledaga Chlormethine Gel for CTCL MF treatment gets EC approval
Posted on March 11, 2017 November 10, 2018 by pharmanewsdaily
Actelion recent news : The European Commission (EC) has approved Actelion Pharmaceuticals’ marketing authorization for its Ledaga Chlormethine Gel 160
Continue reading
Pharma Regulatory News
Leave a comment
AstraZeneca, Sanofi form R&D alliance for infant respiratory drug
Posted on March 6, 2017 November 10, 2018 by pharmanewsdaily
AstraZeneca’s MedImmune and Sanofi Pasteur have formed a research and development alliance for a new infant respiratory drug, MEDI8897 which
Continue reading
Pharma Industry News
Leave a comment
Noctiva becomes first FDA approved treatment for nocturia syndrome
Posted on March 5, 2017 November 10, 2018 by pharmanewsdaily
Serenity Pharmaceuticals’ nasal spray to treat the nocturnal polyuria syndrome in adults, Noctiva (desmopressin acetate) has secured the US FDA
Continue reading
Pharma Regulatory News
Leave a comment
Eczema drug Dupixent succeeds in phase 3 atopic dermatitis clinical trial
Posted on March 5, 2017 November 10, 2018 by pharmanewsdaily
Atopic dermatitis clinical trial : The jointly developed eczema drug, Dupixent (dupilumab) from Sanofi and Regeneron Pharmaceuticals has met the
Continue reading
Clinical Trial News
Leave a comment
Posts navigation
1 2 Next Posts»
Search for:
Search
Latest Pharma Industry News
Dr Reddy’s Laboratories to acquire generic injectable products in the US
Ibrance FDA approval : Pfizer breast cancer drug approved for metastatic breast cancer in men
Novartis to acquire IFM Tre with eye on immunomodulatory drugs
Ethicon wraps up $3.4bn acquisition of robotic medical company Auris Health
US CDMO Brammer Bio to be acquired by Thermo Fisher
Italian CDMO Olon wraps up acquisition of Mahad API plant in India
Lilly teams up with ImmuNext for developing drugs for autoimmune diseases
Arch Oncology raises $50m to advance anti-CD47 antibody therapies
Merck to invest €150m to expand Aubonne biotech manufacturing site
RepHresh brand rolls out RepHresh Cooling Relief Vaginal Anti-Itch Spray
Business News Today
Victoria’s Secret launches summer fragrance collection Bombshell Paradise
CBA to roll out low alcohol, low-calorie Pacer Low Proof Seltzer range
Ameriprise Financial to sell Ameriprise Auto & Home to American Family
Duke Energy inaugurates 1.64GW Citrus County power plant in Florida
Torani rolls out new Puremade range of syrups and sauces
FMG, Formosa approve Iron Bridge Magnetite Project stage 2 development
Campbell Soup to sell Bolthouse Farms to Butterfly Equity for $510m
Center Rock acquires Merit Distribution from Centre Lane Partners
pladis launches chocolate-covered pretzel brand Flipz Mix in US
Dacor opens new kitchen appliance showroom in Chicago
DailyHealthNeeds.com
Know how to use onion juice to help hair grow faster
Know how drumsticks can make your life better
Amazing health benefits of Fava beans
Amazing benefits of rose water for dry skin
Know about Vitamin B12 – The power house of energy, deficiency symtpoms
Archives
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
May 2018
March 2018
December 2017
November 2017
October 2017
September 2017
August 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
Categories
Clinical Trial News Medical Device News Pharma Industry News Pharma Regulatory News
Tags
AbbVie Acute myeloid leukemia adalimumab Advanced solid tumors Amgen Asthma AstraZeneca Atopic dermatitis Breast Cancer Bristol-Myers Squibb California Cambridge cancer China David M. Reese Eli Lilly and Company Europe European Commission European Medicines Agency European Union George D. Yancopoulos Germany Hematology Humira India Janssen Pharmaceuticals Johnson & Johnson Lung cancer Massachusetts Merck Novartis Oncology Ophthalmology Pfizer Regeneron Pharmaceuticals Richard Pazdur Roche Sandoz Sanofi Small cell lung cancer Switzerland Teva Pharmaceutical Industries United Kingdom USA US FDA